CRISPR, short for Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing tool originally discovered as a bacterial defence mechanism. Scientists have repurposed it ...
Scientists had tried to treat diseases by editing genes since the 1990s, but the methods were cumbersome and didn’t pay off. Then in June 2012, the journal Science published a paper by two future ...
The coronavirus disease 2019 (COVID-19) pandemic was one of the most serious public health calamities in the last decade, causing global morbidity and mortality in the millions. The emergence of ...
In a world first, we heard last week that US surgeons had transplanted a kidney from a gene-edited pig into a living human. News reports said the procedure was a breakthrough in xenotransplantation – ...
On Friday, the US Food and Drug Administration approved a sickle cell disease drug called Casgevy, co-developed by Vertex Pharmaceuticals and CRISPR Therapeutics. It’s the first gene editing treatment ...
Dr. Ashley Ellis, a transfusion medicine physician at Stony Brook University Hospital, breaks down how sickle cell disease is diagnosed, the disparities patients face in getting proper care, and the ...
The FDA late last week set for December a groundbreaking decision on whether to grant its first-ever approval for a CRISPR-Cas9 gene-edited therapy—but the milestone so far doesn’t seem to be wowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results